BRIEF published on 02/26/2025 at 07:05, 1 year 2 months ago Gerresheimer annonce une performance financière stable en 2024 malgré les défis Résultats Annuels Bormioli Pharma Croissance Des Revenus Perspectives Financières Défis Du Marché
PRESS RELEASE published on 02/26/2025 at 07:00, 1 year 2 months ago Gerresheimer delivers solid results in the financial year 2024 despite market headwinds Gerresheimer achieves solid results in FY 2024 despite market challenges with organic growth of 2.9% and adjusted EBITDA up 4.1%. Expansion and integration strategies set for growth in 2025 Growth Strategy Financial Results Market Challenges Organic Growth Gerresheimer
BRIEF published on 02/07/2025 at 16:31, 1 year 3 months ago Gerresheimer AG Engages in Preliminary Talks with Private Equity Firms Private Equity Takeover Offer Gerresheimer MDAX Investment Discussions
BRIEF published on 02/07/2025 at 16:31, 1 year 3 months ago Gerresheimer AG entame des discussions préliminaires avec des sociétés de capital-investissement Offre Publique D'achat Capital-investissement MDAX Gerresheim Discussions Sur Les Investissements
PRESS RELEASE published on 02/07/2025 at 16:26, 1 year 3 months ago EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer Gerresheimer AG confirms discussions with private equity investors on potential takeover offer Private Equity Takeover Offer Gerresheimer AG Discussions Potential
BRIEF published on 12/16/2024 at 09:05, 1 year 4 months ago Gerresheimer's Lasix ONYU Receives Tentative FDA Approval Innovation FDA Approval Healthcare Costs Gerresheimer Lasix ONYU
BRIEF published on 12/16/2024 at 09:05, 1 year 4 months ago Le Lasix ONYU de Gerresheimer reçoit une approbation provisoire de la FDA Innovation Approbation De La FDA Coûts Des Soins De Santé Gerresheim Lasix ONYU
PRESS RELEASE published on 12/16/2024 at 09:00, 1 year 4 months ago Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU* FDA grants Tentative Approval of SQ Innovation's Lasix ONYU by Gerresheimer for home treatment of fluid overload in congestive heart failure, with innovative on-body device technology FDA Gerresheimer Lasix ONYU Tentative Approval SQ Innovation
BRIEF published on 12/11/2024 at 08:05, 1 year 4 months ago Gerresheimer Completes Acquisition of Bormioli Pharma Group Pharmaceutical Packaging Market Expansion Financial Growth Gerresheimer Acquisition Bormioli Pharma Integration
BRIEF published on 12/11/2024 at 08:05, 1 year 4 months ago Gerresheimer finalise l'acquisition du groupe pharmaceutique Bormioli Croissance Financière Emballage Pharmaceutique Expansion Du Marché Acquisition De Gerresheimer Intégration De Bormioli Pharma
Published on 05/07/2026 at 22:05, 50 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 18:30, 4 hours 25 minutes ago Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 6 hours 20 minutes ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 7 hours 40 minutes ago ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 20:42, 2 hours 12 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 4 hours 9 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 18:35, 4 hours 19 minutes ago Seminole Hard Rock Casino Named Official Miami World Cup 2026™ Host City Supporter
Published on 05/07/2026 at 18:00, 4 hours 55 minutes ago Correction d’un communiqué du 05.05.2026 21:46 CET/CEST - E-PANGO: Composition du capital au 30 avril 2026
Published on 05/07/2026 at 19:15, 3 hours 40 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 hours 40 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 hours 49 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 hours 49 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 hours 55 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
